Replay available

USANA Health Sciences, Inc. (USNA) Q2 2025 Earnings Call

USANA Health Sciences, Inc. (NYSE: USNA) Q2 2025 earnings conference call, held 2025-07-23. Replay captured from the company's public earnings webcast.

Wed, July 23, 2025 at 11:00 AMendedReplay
USANA Health Sciences, Inc. (USNA) Q2 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Andrew Masuda

Director of Investor Relations

Ivan Feinseth

Analyst, Tigress Financial Partners

Anthony Lebezinski

Analyst, Sidoti & Company

Brent Neidig

Chief Commercial Officer

Walter Note

Chief Operating Officer

Doug Hecking

Chief Financial Officer

Jim Brown

President and Chief Executive Officer

Replay transcript excerpt

Good morning and welcome to the USADA Health Sciences second quarter earnings call. At this time, all participants are in a listen-only mode. A question and answer session will follow a formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. Please note, this conference is being recorded. I will now turn the conference over to your host, Andrew Masuda, Director of Investor Relations. Thank you. You may begin. Thanks, Diego, and good morning, everyone. We appreciate you joining us to review our second quarter results. Today's conference call is being broadcast live via webcast and can be accessed directly from our website at ir.isana.com. Shortly following the call, a replay will be available on our website. As a reminder, during the course of this conference call, management will make forward-looking statements regarding future events or the future financial performance of our company. Those statements involve risks and uncertainties that could cause actual results to differ, perhaps materially, from the results projected in such forward-looking statements. Examples of these statements include those regarding our strategies and outlook for fiscal year 2025, uncertainty related to the economic and operating environment around the world, and our operations and financial results. We caution you that these statements should be considered in conjunction with disclosures, including specific risk factors and financial data contained in our most recent filings with the SEC. I'm joined by our President and CEO, Jim Brown, our Chief Financial Officer, Doug Hecking, our Chief Commercial Officer, Brent Neidig, our Chief Operating Officer, Walter Note, as well as other executives. Yesterday, after t...

More from Usana Health Sciences, Inc.